Work

GPCR Screening via ERK 1/2: A Novel Platform for Screening G Protein–Coupled Receptors

Year: 2005
Type: article
Abstract: Discovery of novel agonists and antagonists for G protein-coupled receptors (GPCRs) relies heavily on cell-based assays because determination of functional consequences of receptor engagement is often desirable. Currently, there are several key parameters measured to achieve this, including mobilization of intracellular Ca2+ and formation of cyclic adenosine monophosphate or inositol triphosphate. However, no single assay platform is suitable for all situations, and all of the assays have limitations. The authors have developed a new high-throughput homogeneous assay platform for GPCR discovery as an alternative to current assays, which employs detection of phosphorylation of the key signaling molecule p42/44 MAP kinase (ERK 1/2). The authors show that ERK 1/2 is consistently activated in cells stimulated by Gq-coupled GPCRs and provides a new high-throughput platform for screening GPCR drug candidates. The activation of ERK 1/2 in Gq-coupled GPCR systems generates comparable pharmacological data for receptor agonist and antagonist data obtained by other GPCR activation measurement techniques.
Authors: Ronald I.W. Osmond, Antony Sheehan, Romana Borowicz, Emma Barnett, Georgina Harvey, Cheryl Turner, Andrea Brown, Michael F. Crouch, Anthony R. Dyer
Language: English
Open Access status: hybrid
Estimated APC paid: $2,070
OpenAlex ID: W2143801729
FWCI: 1.325
Cites: 29
Cited by: 79
Related to: 8